Filing Details
- Accession Number:
- 0001214659-20-000466
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-21 18:59:25
- Reporting Period:
- 2020-01-16
- Accepted Time:
- 2020-01-21 18:59:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1076682 | Polarityte Inc. | PTE | Biological Products, (No Disgnostic Substances) (2836) | 061529524 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1691208 | Denver Lough | 8 East Broadway, Suite 320 Salt Lake City UT 84111 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock (From Stock Option) | Acquisiton | 2020-01-16 | 10,000 | $3.12 | 10,000 | No | 4 | M | Indirect | Spouse's Employee Stock from Stock Option |
Common Stock (From Stock Option) | Disposition | 2020-01-16 | 10,000 | $4.17 | 0 | No | 4 | S | Indirect | Spouse's Employee Stock from Stock Option |
Common Stock (From Stock Option) | Disposition | 2020-01-16 | 0 | $4.14 | 0 | No | 4 | F | Indirect | Spouse's Employee Stock from Stock Option |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | Spouse's Employee Stock from Stock Option |
No | 4 | S | Indirect | Spouse's Employee Stock from Stock Option |
No | 4 | F | Indirect | Spouse's Employee Stock from Stock Option |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2020-01-16 | 10,000 | $0.00 | 10,000 | $3.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | 2018-12-16 | 2020-02-15 | No | 4 | M | Indirect |
Footnotes
- On January 16, 2020 the full stock option to exercise 10,000 options at an exercise price of $3.12 was conducted by the Issuer's broker. The resultant converted 10,000 shares were then immediately sold by the Issuer's broker into the open market. The cash proceeds from the sale were used to pay the exercise cost, required tax withholding, brokerage commissions and fees. The sale price of $4.17 represents a weighted average price as multiple executions were involved in completing the exercise transaction. Additional detail regarding the individual execution prices is available upon request.
- See prior Form-4 filed on December 19, 2016 (as described in remarks section of this filing)